MEDICAMEN BIOTECH
Back to Cashflow Statement
|
MEDICAMEN BIOTECH Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-5.99 Cr | ₹17 Cr | ₹-0.07 Cr | ₹0.80 Cr | ₹-5.43 Cr |
What is the latest Net Cash Inflow / Outflow ratio of MEDICAMEN BIOTECH ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-5.99 Cr |
Mar2023 | ₹17 Cr |
Mar2022 | ₹-0.07 Cr |
Mar2021 | ₹0.80 Cr |
Mar2020 | ₹-5.43 Cr |
How is Net Cash Inflow / Outflow of MEDICAMEN BIOTECH Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-5.99 Cr | Negative | |
Mar2023 | ₹17 Cr | Positive | |
Mar2022 | ₹-0.07 Cr | Negative | |
Mar2021 | ₹0.80 Cr | Positive | |
Mar2020 | ₹-5.43 Cr | - |
Compare Net Cash Inflow / Outflow of peers of MEDICAMEN BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICAMEN BIOTECH | ₹650.5 Cr | 9.3% | 6.8% | 1.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
MEDICAMEN BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICAMEN BIOTECH | 9.3% |
6.8% |
1.1% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses